Raymond James Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Raymond James Trust's IDXX Position: Q3 2024 in Review
Raymond James Trust increased its Idexx Laboratories (IDXX) stake by 67% in Q3 2024, buying an estimated $758K and bringing the position to 3,879 shares worth $1.96M. The position accounts for 0.04% of the portfolio, ranked #327.
Raymond James Trust first reported a position in IDXX in Q4 2015 and has held it in 20 quarters since. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.
- Raymond James Trust held 3,879 shares of Idexx Laboratories worth $1.96M as of Q3 2024.
- Raymond James Trust bought 1,561 Idexx Laboratories shares in Q3 2024, an estimated $758K.
- Idexx Laboratories made up 0.04% of Raymond James Trust's portfolio in Q3 2024, its #327 holding.
- Raymond James Trust first reported a position in Idexx Laboratories in Q4 2015 and has held it in 20 quarters since.
- 1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.